Crawford, K., Heatley, N. G., Boyd, P. F., Hale, C. W., Kelly, B. K., Miller, G. A., and Smith, N., J. Gen. Microbiol., 6, 47 (1952).

Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

In a week marked by geopolitical tensions and consumer spending concerns, major U.S. indices saw declines, with the S&P 500 experiencing sharp losses that erased early gains. As broader market ...